Your current location:HOME >business >Eli Lilly's new ad says weight 正文
TIME:2024-04-30 12:23:03 Source: Internet compilationEdit:business
FDA approves weight loss drug Zepbound, joining Ozempic and Wegovy in market 04:47
Eli Lilly has a message for people who are taking prescription medications developed for patients with Type 2 diabetes and obesity: Don't take the drugs just because you want to look good.
The message, delivered in a new Hollywood-themed ad called "Big Night," will air this weekend and is timed to coincide with Sunday's broadcast of the Oscars. The spot opens with a shot of a sequined gown, suggesting that the woman voicing the campaign is preparing for a formal event.
"Some people have been using medicine never meant for them. For the smaller dress or tux, for a big night, for vanity," the character in the ad says. The camera then pans to a theater resembling the one in which the Academy Awards are handed out. The point is clear: Drugs like Lilly's Mounjaro or Novo Nordisk's Ozempic and Wegovy aren't intended for general weight loss.
"People whose health is affected by obesity are the reason we work on these medications. It matters who gets them," the ad says.
Mounjaro is used to treat patients with Type 2 diabetes. But the drug and similar medications have soared in popularity among people who aren't diabetic but who want to shed a few pounds to improve their appearance. Lilly also makes Zepbound, which is indicated for adults with obesity.
This year's Oscars host, Jimmy Kimmel, opened the 2023 awards ceremony by poking fun at Ozempic.
"Everybody looks so great. When I look around this room I can't help but wonder, 'Is Ozempic right for me?'" he quipped.
In a statement ahead of its new ad, Lilly underlined that people shouldn't take drugs like Mounjaro just because they want to be slimmer.
The ad "addresses a topic that has been part of the cultural dialogue at recent high-profile awards ceremonies: the use of anti-obesity medications outside their FDA-approved indications," the company said. "Patient safety is Lilly's top priority, and our medicines are indicated for the treatment of serious diseases."
The drugmaker also makes clear that the medications are only approved for certain uses.
"They were not studied for, are not approved for, and should not be used for cosmetic weight loss, and at Lilly we believe it is important that, in consultation with their health care providers, the right people can get access to these medicines," Lilly said.
In a separate open letter regarding how such drugs are use, Lilly said "stands against the use of its medicines for cosmetic weight loss."
President Xi on global, regional security2024-04-30 12:12
US says UFO sightings likely secret military tests2024-04-30 11:46
Schools not equipped to be community hubs in disaster responses2024-04-30 11:25
WorkSafe interim chief executive Steve Haszard resigns months into job2024-04-30 10:48
Duo charged with murder in killings of couple whose remains were found scattered on Long Island2024-04-30 10:47
Tens of thousands turn out for King Frederik's succession2024-04-30 10:42
Māori Hui aa motu movement backed by Pacific leaders2024-04-30 10:30
Department of Conservation 'spread too thin', Penny Nelson tells select committee2024-04-30 10:24
Rubiales denies wrongdoing when questioned in probe into Saudi Arabia deal for Spanish Super Cup2024-04-30 10:19
Israel launches night raid on Gaza al2024-04-30 09:47
Israeli airstrike kills 14 in Gaza's refugee camp2024-04-30 12:13
Iwi Chairs Forum reps pull out of anti2024-04-30 12:08
WorkSafe interim chief executive Steve Haszard resigns months into job2024-04-30 11:40
Fire kills 29 people at Istanbul nightclub during daytime renovations2024-04-30 11:38
Explosion kills 3 including 2 children in Myanmar's Yangon2024-04-30 11:28
More than 350 school building projects under review, Ministry of Education documents show2024-04-30 11:27
University enrolments drop at Otago, rise at Waikato2024-04-30 11:21
'We will not be silenced': Gisborne council backs Māori wards2024-04-30 11:14
Sea off New England had one of its hottest years in 2023, part of a worldwide trend2024-04-30 10:52
West Coast emergency staff preparing for deluge2024-04-30 10:30